1.A multi-omics-empowered framework for precision diagnosis and treatment of lysosomal diseases.
Nguyen Thi Hai YEN ; Nguyen Tran Nam TIEN ; Nguyen Quang THU ; Franklin DUCATEZ ; Wladimir MAUHIN ; Olivier LIDOVE ; Soumeya BEKRI ; Abdellah TEBANI ; Nguyen Phuoc LONG
Journal of Pharmaceutical Analysis 2025;15(10):101274-101274
Lysosomal diseases (LDs) are a group of rare inherited disorders belonging to inborn metabolism errors. LDs are characterized by the excessive storage of undegraded substrates, most often due to the enzymatic deficiency resulting from disease-causing gene variants. LDs lead to dysregulated cellular pathways and imbalanced molecular homeostasis and can affect multiple organs and tissues. Despite being rare, LDs account for a significant incidence when considered collectively. Due to complex molecular and genetic fingerprints, considerable challenges in LD management must be overcome. Diagnosis can be significantly delayed due to the broad and nonspecific clinical manifestations and the lack of specific biomarkers. Available treatments fail to fully stop the disease progression and can alter the disease's typical phenotypes with novel manifestations. Therefore, a paradigm shift is crucial to better understand LDs and provide actionable insights. Herein, we comprehensively review the literature to demonstrate that multi-omics approaches are promising for pathophysiology elucidation, biomarker discovery, and precision therapy in LDs. We recommend adopting longitudinal study designs integrated with a multi-omics-empowered framework to facilitate mechanistic delineation, biomarker discovery, and treatment development. Relevant approaches exploring the association between LDs and common neurodegenerative disorders are also discussed, paving a potential path for improved therapeutic development and ultimately improving the patient's quality of life.
2.Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management.
Nguyen Quang THU ; Nguyen Tran Nam TIEN ; Nguyen Thi Hai YEN ; Thuc-Huy DUONG ; Nguyen Phuoc LONG ; Huy Truong NGUYEN
Journal of Pharmaceutical Analysis 2024;14(1):16-38
The spread of tuberculosis (TB), especially multidrug-resistant TB and extensively drug-resistant TB, has strongly motivated the research and development of new anti-TB drugs. New strategies to facilitate drug combinations, including pharmacokinetics-guided dose optimization and toxicology studies of first- and second-line anti-TB drugs have also been introduced and recommended. Liquid chromatography-mass spectrometry (LC-MS) has arguably become the gold standard in the analysis of both endo- and exo-genous compounds. This technique has been applied successfully not only for therapeutic drug monitoring (TDM) but also for pharmacometabolomics analysis. TDM improves the effectiveness of treatment, reduces adverse drug reactions, and the likelihood of drug resistance development in TB patients by determining dosage regimens that produce concentrations within the therapeutic target window. Based on TDM, the dose would be optimized individually to achieve favorable outcomes. Pharmacometabolomics is essential in generating and validating hypotheses regarding the metabolism of anti-TB drugs, aiding in the discovery of potential biomarkers for TB diagnostics, treatment monitoring, and outcome evaluation. This article highlighted the current progresses in TDM of anti-TB drugs based on LC-MS bioassay in the last two decades. Besides, we discussed the advantages and disadvantages of this technique in practical use. The pressing need for non-invasive sampling approaches and stability studies of anti-TB drugs was highlighted. Lastly, we provided perspectives on the prospects of combining LC-MS-based TDM and pharmacometabolomics with other advanced strategies (pharmacometrics, drug and vaccine developments, machine learning/artificial intelligence, among others) to encapsulate in an all-inclusive approach to improve treatment outcomes of TB patients.
3.Study on the effective control of postpreal blood glucose of resistant starch cakes in patients with type 2 diabetes
Huu Dung TRAN ; Quang Hung LE ; Bao Dung VO ; Hoang Vu NGUYEN ; Thanh Bao Yen LUONG ; That Hy TON ; Phuoc Hieu DOAN ; Thi Bich Hien PHAM ; Huu Tien NGUYEN ; Hai Thuy NGUYEN
Hue Journal of Medicine and Pharmacy 2023;13(7):52-58
Background: This study was conducted on 93 volunteers with type 2 diabetes to investigate the ability of acetylated wheat starch cake containing 32.1% resistant starch to control postprandial blood glucose levels. Material and methods: The study was designed using a crossover, double-blind trial method. During each testing day, after a minimum of 12 hours of overnight fasting, each participant consumed two identical cakes containing either 80 g of acetylated wheat starch or 80 g natural wheat starch with 330ml of water within 15 minutes. Blood glucose levels were measured at baseline, 60 mins (G1), and 120 mins (G2) after ingestion. The predictive value of factors that contribute to the ability of resistant starch to control postprandial blood glucose was determined by the area under the receiver operating characteristic (ROC) curve based on the combined effect of the cake weight-to-BMI ratio (g/m²BMI) and HbA1c. Results: 60 mins and 120 mins postprandial capillary glucose levels after consuming acetylated wheat starch cake (10.4 ± 1.2 và 9.2 ± 1.2 mmol/L, respectively) were significantly lower compared with natural wheat starch cake (13.3 ± 1.8 và 11.2 ± 1.8 mmol/L, respectively) (p < 0.05). For good control of postprandial blood glucose levels, a maximum of 80 g of acetylated wheat starch can be used per serving for patients with type 2 diabetes with HbA1c ≤ 7.25 without blood glucose-lowering medication is required. Conclusion: acetylated wheat starch has better ontroled of postprandial blood glucose compared with natural wheat starch in patients with type 2 diabetes. This is very suitable in the processing of diets including resistant starch for patients with type 2 diabetes for the purpose of both supporting treatment and improving quality of life.
4.Multiple Exposures and Coexposures to Occupational Hazards Among Agricultural Workers: A Systematic Review of Observational Studies.
Thi Hai Yen NGUYEN ; Mélanie BERTIN ; Julie BODIN ; Natacha FOUQUET ; Nathalie BONVALLOT ; Yves ROQUELAURE
Safety and Health at Work 2018;9(3):239-248
BACKGROUND: Workers may be exposed to various types of occupational hazards at the same time, potentially increasing the risk of adverse health outcomes. The aim of this review was to analyze the effects of multiple occupational exposures and coexposures to chemical, biomechanical, and physical hazards on adverse health outcomes among agricultural workers. METHODS: Articles published in English between 1990 and 2015 were identified using five popular databases and two complementary sources. The quality of the included publications was assessed using the methodology developed by the Effective Public Health Practice Project assessment tool for quantitative studies. RESULTS: Fifteen articles were included in the review. Multiple chemical exposures were significantly associated with an increased risk of respiratory diseases, cancer, and DNA and cytogenetic damage. Multiple physical exposures seemed to increase the risk of hearing loss, whereas coexposures to physical and biomechanical hazards were associated with an increased risk of musculoskeletal disorders among agricultural workers. CONCLUSION: Few studies have explored the impact of multiple occupational exposures on the health of agricultural workers. A very limited number of studies have investigated the effect of coexposures among biomechanical, physical, and chemical hazards on occupational health, which indicates a need for further research in this area.
Cytogenetics
;
DNA
;
Farmers*
;
Hearing Loss
;
Occupational Exposure
;
Occupational Health
;
Public Health Practice
5.Key containers of Aedes species, vectors to transmit dengue viruses in Nam Dinh province, 2007
Duoc Trong Vu ; Yen Thi Nguyen ; Son Hai Tran ; Dung Chi Tham ; Luu Duc Do
Journal of Preventive Medicine 2008;18(1):15-20
Background: Dengue Fever/Dengue Hemorrhagic Fever (DF/DHF) has emerged as one of the most important public health concerns in Viet Nam in recent years. Key breeding containers plays an important role in driving dengue vector control in the public. Objectives: The research was conducted to discover the dengue situation, its vectors and key containers to make relevant recommendations in reducing effectively the vector population. Subjects and methods: Two hundred households in two communes of Nam Dinh province (100 in each studied commune) were selected randomly. Vectors collected from the field were identified using mosquito key. The number of dengue larvae and mosquitoes were directly counted or adjustment methods were used to estimate the true number in each type of water storage facility. Results: In Minh Thuan commune, Ae. albopictus larvae were mainly concentrated in jars (49%) and discards (59%), most of Ae. aegypti was found in cement tanks with a volume more than 500L (72%). In Trung Dong commune, larvae of Ae. albopictus concentrated in jars (40%) and discards (25%) and aquariums (15%), while most of the Ae. aegypti larvae was discovered in cement tanks with volumes more than 500L (86%). Mosquito density index of Ae. albopictus in Trung Dong and Minh Thuan communes was 0.56 and 0.38, respectively. The Aedes larvae, houses for larvae and Breteau index were nearly at the threshold of dengue epidemic occurrence for Ae. aegypti and over a certain threshold for Ae. albopictus. Some recommendations were provided to help reduce the dengue vectors. Conclusion: Investigation of key mosquito larvae in water containers was useful in driving the effective dengue vector control. Further studies are required to evaluate the impact and methods to manage water containers in the local area.
Dengue fever
;
mosquito
;
vector control

Result Analysis
Print
Save
E-mail